HIGHLIGHTS
- who: Xinzhou Wu from the (UNIVERSITY) have published the research: Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier, in the Journal: (JOURNAL) of July/20,/2020
- what: Note that each experiment in this study has no less than 2 technical replicates.
SUMMARY
As a highly heterogeneous hematological malignancy, acute myeloid leukemia (AML) is characterized by immature myeloid cell proliferation and bone marrow failure. In fact, as the most effective drug against AML, the free pyrimidine analog cytarabine arabinoside (Ara . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.